In vitro inhibitory effects of dihydromyricetin on human liver cytochrome P450 enzymes

References

• Bi W, He C, Ma Y, Shen J, Zhang LH, Peng Y, Xiao P. 2016. Investigation of free amino acid, total phenolics, antioxidant activity and purine alkaloids to assess the health properties of non-Camellia tea. Acta Pharm Sin B. 6:170–181.
   PubMed Web of Science ®Google Scholar
• Bostikova Z, Moserova M, Pavek P, Stiborova M, Hodek P. 2015. Role of dihydromyricetin in cytochrome P450-mediated metabolism and carcinogen activation. Neuro Endocrinol Lett. 36 Suppl 1:46–52.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu Y, Zou J, Gao K. 2016. α-Glucosidase inhibition and antihyperglycemic activity of flavonoids from Ampelopsis grossedentata and the flavonoid derivatives. Bioorg Med Chem. 24:1488–1494.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhao X, Wan J, Ran L, Qin Y, Wang X, Gao Y, Shu F, Zhang Y, Liu P, et al. 2015. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial. Pharmacol Res. 99:74–81.
   PubMed Web of Science ®Google Scholar
• Chiangsom A, Lawanprasert S, Oda S, Kulthong K, Luechapudiporn R, Yokoi T, Maniratanachote R. 2016. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450. Drug Metab Pharmacokinet. 31:210–217.
   PubMed Web of Science ®Google Scholar
• Du Q, Cai W, Xia M, Ito Y. 2002. Purification of (+)-dihydromyricetin from leaves extract of Ampelopsis grossedentata using high-speed countercurrent chromatograph with scale-up triple columns. J Chromatogr A. 973:217–220.
   PubMed Web of Science ®Google Scholar
• Ericsson T, Sundell J, Torkelsson A, Hoffmann KJ, Ashton M. 2014. Effects of artemisinin antimalarials on cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies. Xenobiotica. 44:615–626.
   PubMed Web of Science ®Google Scholar
• Hou XL, Tong Q, Wang WQ, Shi CY, Xiong W, Chen J, Liu X, Fang JG. 2015. Suppression of inflammatory responses by dihydromyricetin, a flavonoid from Ampelopsis grossedentata, via inhibiting the activation of NF-κB and MAPK signaling pathways . J Nat Prod. 78:1689–1696.
   PubMed Web of Science ®Google Scholar
• Hu X, Huang W, Yang Y. 2015. Cytochrome P450 isoenzymes in rat and human liver microsomes associate with the metabolism of total coumarins in Fructus cnidii. Eur J Drug Metab Pharmacokinet. 40:373–377.
   PubMed Web of Science ®Google Scholar
• Ito K, Iwatsubo T, Kanamitsu S, Nakajima Y, Sugiyama Y. 1998. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport. Annu Rev Pharmacol Toxicol. 38:461–499.
   PubMed Web of Science ®Google Scholar
• Ji FJ, Tian XF, Liu XW, Fu LB, Wu YY, Fang XD, Jin HY. 2015. Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells. Genet Mol Res. 14:15564–15571.
   PubMed Web of Science ®Google Scholar
• Jiang B, Le L, Pan H, Hu K, Xu L, Xiao P. 2014. Dihydromyricetin ameliorates the oxidative stress response induced by methylglyoxal via the AMPK/GLUT4 signaling pathway in PC12 cells. Brain Res Bull. 109:117–126.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee JY, Kang W, Kwon KI, Park SK, Oh SJ, Ma JY, Kim SK. 2013. Cytochrome P450-mediated herb–drug interaction potential of Galgeun-tang. Food Chem Toxicol. 51:343–349.
   PubMed Web of Science ®Google Scholar
• Li AP. 2001. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today. 6:357–366.
   PubMed Web of Science ®Google Scholar
• Li YS. 2006. Effects of Enshi-Ampelopsis grossede on serum lipid and blood rheology and oxygen free radical of hyperlipidemia model rats. J Hubei Inst Natl Med Ed. 23:7–9.
   Google Scholar
• Liu J, Shu Y, Zhang Q, Liu B, Xia J, Qiu M, Miao H, Li M, Zhu R. 2014. Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells. Oncol Lett. 8:1645–1651.
   PubMed Web of Science ®Google Scholar
• Louis A, Petereit F, Lechtenberg M, Deters A, Hensel A. 2010. Phytochemical characterization of Rhododendron ferrugineum and in vitro assessment of an aqueous extract on cell toxicity. Planta Med. 76:1550–1557.
   PubMed Web of Science ®Google Scholar
• Meng G, Yang S, Chen Y, Yao W, Zhu H, Zhang W. 2015. Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner. Pharm Biol. 53:904–912.
   PubMed Web of Science ®Google Scholar
• Meng Q, Liu K. 2014. Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters. Curr Drug Metab. 15:791–807.
   PubMed Web of Science ®Google Scholar
• Pandit S, Mukherjee PK, Ponnusankar S, Venkatesh M, Srikanth N. 2011. Metabolism mediated interaction of α-asarone and Acorus calamus with CYP3A4 and CYP2D6. Fitoterapia. 82:369–374.
   PubMed Web of Science ®Google Scholar
• Pirotta M, Willis K, Carter M, Forsdike K, Newton D, Gunn J. 2014. 'Less like a drug than a drug': the use of St. John's wort among people who self-identify as having depression and/or anxiety symptoms. Complement Ther Med. 22:870–876.
   PubMed Web of Science ®Google Scholar
• Qi XY, Liang SC, Ge GB, Liu Y, Dong PP, Zhang JW, Wang AX, Hou J, Zhu LL, Yang L, et al. 2013. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes. Food Chem Toxicol. 56:392–397.
   PubMed Web of Science ®Google Scholar
• Qin J, Zhong Z, Zhou G, Chen X. 2001. The experimental studies of dihydromyricetin on antidiabetic effect. Chin J Mod Appl Pharm. 18:351.
   Google Scholar
• Ryu CS, Oh SJ, Oh JM, Lee JY, Lee SY, Chae JW, Kwon KI, Kim SK. 2016. Inhibition of cytochrome P450 by propolis in human liver microsomes. Toxicol Res. 32:207–213.
   PubMed Web of Science ®Google Scholar
• Tao X, Zheng L, Qi Y, Xu Y, Xu L, Yin L, Han X, Liu K, Peng J. 2014. Inhibitory effects of dioscin on cytochrome P450 enzymes. RSC Adv. 4:54026–54031.
   Web of Science ®Google Scholar
• Tong Q, Hou X, Fang J, Wang W, Xiong W, Liu X, Xie X, Shi C. 2015. Determination of dihydromyricetin in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. J Pharm Biomed Anal. 114:455–461.
   PubMed Web of Science ®Google Scholar
• Unger M. 2013. Pharmacokinetic drug interactions involving Ginkgo biloba. Drug Metab Rev. 45:353–385.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q. 2015. Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther Clin Risk Manag. 11:449–467.
   PubMed Web of Science ®Google Scholar
• Wei JC, Meng F, Qu K, Wang ZX, Wu QF, Zhang LQ, Pang Q, Liu C. 2015. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1. Acta Pharmacol Sin. 36:241–251.
   Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. 1992. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol. 22:1–21.
   PubMed Web of Science ®Google Scholar
• Xia J, Guo S, Fang T, Feng D, Zhang X, Zhang Q, Liu J, Liu B, Li M, Zhu R. 2014. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways. Food Chem Toxicol. 66:7–13.
   PubMed Web of Science ®Google Scholar
• Yan Z, Caldwell GW. 2001. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Curr Top Med Chem. 1:403–425.
   PubMedGoogle Scholar
• Yang JM, Ip SP, Xian Y, Zhao M, Lin ZX, Yeung JH, Chan RC, Lee SS, Che CT. 2012. Impact of the herbal medicine Sophora flavescens on the oral pharmacokinetics of indinavir in rats: the involvement of CYP3A and P-glycoprotein. PLoS One. 7:e31312.
   PubMed Web of Science ®Google Scholar
• Yin S, Sykes ML, Davis RA, Shelper T, Avery VM, Camp D, Quinn RJ. 2010. New galloylated flavanonols from the Australian plant Glochidion sumatranum. Planta Med. 76:1877–1881.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ya G, Rui H. 2016. Inhibitory effects of triptolide on human liver cytochrome P450 enzymes and P-glycoprotein. Eur J Drug Metab Pharmacokinet. 42:89–98.
   Web of Science ®Google Scholar
• Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, et al. 2007. Inhibition of human liver cytochrome P450 by star fruit juice. J Pharm Pharm Sci. 10:496–503.
   PubMed Web of Science ®Google Scholar
• Zhang YS, Zhang QY, Li LY, Wang B, Zhao YY, Guo DA. 2007. Simultaneous determination and pharmacokinetic studies of dihydromyricetin and myricetin in rat plasma by HPLC-DAD after oral administration of Ampelopsis grossedentata decoction. J Chromatogr B: Analyt Technol Biomed Life Sci. 860:4–9.
   PubMed Web of Science ®Google Scholar
• Zhong S, Kong Y, Zhou L, Zhou C, Zhang X, Wang Y. 2014. Efficient conversion of myricetin from Ampelopsis grossedentata extracts and its purification by MIP-SPE. J Chromatogr B: Analyt Technol Biomed Life Sci. 945–946:39–45.
   PubMed Web of Science ®Google Scholar
• Zhou S, Chan E, Li SC, Huang M, Chen X, Li X, Zhang Q, Paxton JW. 2004. Predicting pharmacokinetic herb–drug interactions. Drug Metabol Drug Interact. 20:143–158.
   PubMedGoogle Scholar
• Zhou SF. 2008. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab. 9:310–322.
   PubMed Web of Science ®Google Scholar